venetoclax,obinutuzumab,belantamab mafodotin,teclistamab,ibrutinib,belantamab
genmab,janssen,gsk,Abbvie,roche
['belantamab mafodotin', 'mmsm', 'belantamab', 'teclistamab', 'multiple myeloma']
comparison of teclistamab with belantamab mafodotin in patients with triple-class exposed relapsed/refractory multiple myeloma using matching-adjusted indirect treatment comparison (p898) #mmsm #eha2022 
Professor of hematology, Universitary hospital of Sidi Bel Abbés.
Head, Hospitalisation and  Geriatric Unit.